Ziebarth aj et al. – this chapter reviews progress in the development of novel therapies directed at major pathways implicated in ovarian tumorigenesis including angiogenesis, parp inhibition, signal transduction, antifolate therapies, death receptor–mediated therapies, histone deacetylase inhibition, immunotherapeutics, and oncolytics. [more...]
© 2015 M3 USA Corporation. ALL Rights Reserved.